Iron Deficiency Anemia
📧 Sign up to get email alerts when something new happens for Iron Deficiency Anemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-11-20Clinical Trial Update: Iron Status, Maternal Depressive Symptoms, and Mother-child Interactions [NA]
A clinical trial investigating iron status, maternal depressive symptoms, and mother-child interactions related to iron deficiency anemia ha…
-
CLINICAL_TRIALS withdrawal · 2025-11-20Clinical Trial Update: Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease [Phase 3]
The Phase 3 trial evaluating KRX-0502 (ferric citrate) for iron deficiency anemia in children with non-dialysis dependent chronic kidney dis…
-
CLINICAL_TRIALS withdrawal · 2025-07-09Clinical Trial Update: Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma [Phase 2]
Phase 2 trial of intravenous iron in combination with standard-of-care immunotherapy for melanoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-08-28Clinical Trial Update: Polyglucoferron Compared to i.v. Ferric Carboxymaltose and Oral Iron Substitution in Preoperative Treatment of Iron Deficiency Anaemia in Patients [Phase 3]
Phase 3 trial comparing polyglucoferron with intravenous ferric carboxymaltose and oral iron for preoperative treatment of iron deficiency a…
-
EMA withdrawal · 2023-07-11EMA Application withdrawn: Feraheme (Ferumoxytol) — Covis Pharma Europe B.V.
EMA has withdrawn the application for Feraheme (ferumoxytol) by Covis Pharma Europe B.V. in the anemia/iron-deficiency indication.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2019-06-05Clinical Trial Update: A Randomized Study to Compare the Dosing Schedule of INFeD in Anemic Patients. [Phase 4]
A Phase 4 randomized trial evaluating INFeD dosing schedules in patients with iron deficiency anemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-03-15Clinical Trial Update: Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease [Phase 4]
A Phase 4 clinical trial evaluating ergocalciferol for iron metabolism in chronic kidney disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-01-24Clinical Trial Update: Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum) [Phase 4]
Phase 4 safety assessment study for iron sucrose in CKD patients intolerant to other iron therapies has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-10-18Clinical Trial Update: The Safety of a High-Dose, Rapid Infusion of Iron Sucrose [Phase 2]
Phase 2 trial evaluating the safety of a high-dose, rapid infusion of iron sucrose for iron deficiency was withdrawn before completion.
-
CLINICAL_TRIALS withdrawal · 2016-09-28Clinical Trial Update: A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo [Phase 3]
A Phase 3 randomized, double-blind trial comparing intravenous iron isomaltoside 1000 (Monofer) to placebo has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-09-14Clinical Trial Update: A Pilot Study Comparing Tolerance of Oral Heme Iron Polypeptide With Oral Ionic Iron [Phase 4]
A Phase 4 pilot trial comparing tolerance of oral heme iron polypeptide versus oral ionic iron for iron deficiency was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-20Clinical Trial Update: Helicobacter Pylori and Iron Deficiency: Prevalence of Association and Effect of Therapy [Phase 4]
Phase 4 clinical trial evaluating the association between Helicobacter pylori infection and iron-deficiency anemia and the impact of therapy…
-
CLINICAL_TRIALS withdrawal · 2014-01-07Clinical Trial Update: IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD [Phase 2]
A Phase 2 trial comparing intravenous iron sucrose versus oral ferrous sulfate for iron deficiency anemia in children with inflammatory bowe…